Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Sonoma Pharmaceuticals (SNOA) Shares Outstanding (2016 - 2025)

Sonoma Pharmaceuticals has reported Shares Outstanding over the past 15 years, most recently at $1.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 7.11% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, up 7.11%, while the annual FY2025 figure was $1.6 million, 109.42% up from the prior year.
  • Shares Outstanding for Q4 2025 was $1.7 million at Sonoma Pharmaceuticals, up from $1.6 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $3.1 million in Q4 2022 and troughed at $246678.0 in Q1 2023.
  • A 5-year average of $1.8 million and a median of $1.6 million in 2025 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: crashed 92.05% in 2023 and later surged 416.91% in 2024.
  • Year by year, Shares Outstanding stood at $3.1 million in 2021, then increased by 0.33% to $3.1 million in 2022, then plummeted by 78.0% to $684217.0 in 2023, then skyrocketed by 136.15% to $1.6 million in 2024, then increased by 7.11% to $1.7 million in 2025.
  • Business Quant data shows Shares Outstanding for SNOA at $1.7 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.